flu News
Most Popular flu Story
Intercell snaps up Iomai in $189M deal
The little Maryland-based vaccine developer Iomai, which has posted some impressive data on a new therapy for Read more...
Latest Headlines
- September 15, 2009
- August 10, 2009
- June 16, 2008
- May 13, 2008
- April 23, 2008
- April 16, 2008
- March 11, 2008
- March 10, 2008
- February 22, 2008
- January 31, 2008
- January 17, 2008
- November 7, 2007
- January 17, 2007
- January 15, 2007
- January 7, 2007
- November 13, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
